FDANews
www.fdanews.com/articles/195466-cutting-edges-direct-lateral-interbody-fusion-system-cleared
ClearanceStamp_Blue.gif

Cutting Edge’s Direct Lateral Interbody Fusion System Cleared

January 13, 2020

Cutting Edge Spine has earned 510(k) clearance for its EVOL ha-DLIF (direct lateral interbody fusion system) implant for treating leg and back pain resulting from degenerative disc disease.

The implant uses Invibio Material Solutions’ PEEK-OPTIMA HA material, which helps to encourage early onset bone formation and is radiolucent to enable easy imaging.

DLIF is a minimally invasive spinal procedure that allows surgeons to access the treatment area from the patient’s side, reducing the risk of disrupting surrounding tissues and structures.

View today's stories